Cargando…
Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031218/ http://dx.doi.org/10.1371/journal.pone.0098836 |
| _version_ | 1782317504482246656 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4031218 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40312182014-05-28 Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study PLoS One Correction Public Library of Science 2014-05-22 /pmc/articles/PMC4031218/ http://dx.doi.org/10.1371/journal.pone.0098836 Text en © 2014 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| spellingShingle | Correction Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study |
| title | Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study |
| title_full | Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study |
| title_fullStr | Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study |
| title_full_unstemmed | Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study |
| title_short | Correction: Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study |
| title_sort | correction: plasma ykl-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: results from the nordic vii study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031218/ http://dx.doi.org/10.1371/journal.pone.0098836 |
| work_keys_str_mv | AT correctionplasmaykl40inpatientswithmetastaticcolorectalcancertreatedwithfirstlineoxaliplatinbasedregimenwithorwithoutcetuximabresultsfromthenordicviistudy |